After many lines of therapy,lenalidomideis a palliative treatment that is well- reported.
Green A, Shen YP, Nelson AT, Sarode R, Ibrahim IF, Cao J, Afraz S, Yates SG. Successful use of lenalidomide to treat refractory acquired von Willebrand disease associated with monoclonal gammopathy. Ann Hematol. 2022 Dec;101(12):2627-2631. doi: 10.1007/s00277-022-04991-9. Epub 2022 Oct 4. PMID: 36194257; PMCID: PMC9530414.
Sandra Marten et al, Successful treatment of acquired von Willebrand syndrome in multiple myeloma. Thrombosis Update Volume 7, May 2022, 100108